Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Characterization of clonal evolution of T-cell lymphoma


   Department of Pathology

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof M Q Du  No more applications being accepted  Competition Funded PhD Project (European/UK Students Only)

About the Project

It has long been assumed that malignant T-cell lymphoma is a monoclonal disease. i.e. the tumour grows and expands from a single cell. In contrast to this traditional view, our ongoing investigations show for the first time evidence of bi- or oligo-clonal T-cell populations in angioimmunoblastic T-cell lymphoma and its related entities. It is imperative to investigate whether each of these different clonal T-cell populations in a T-cell lymphoma is neoplastic, derived from a common progenitor cell population, and how they impact on disease presentation and treatment responses.

Full details of the projects and how to apply are available from the following link: http://www.path.cam.ac.uk/graduate/fully-funded-studentships.
*Please quote reference PK17049 on your application and in any correspondence about this vacancy.

Funding Notes

The studentships are available to students who qualify for Home/EU fees. Further information at: http://www.graduate.study.cam.ac.uk/finance/fees/what-my-fee-status.

Funding will cover the student's stipend at the current Research Council rate and University Fees. The studentships will be funded for three years in the first instance subject to eligibility with the possibility of additional funding in the fourth year depending on circumstances.

Applicants should hold or be about to achieve a First or Upper-Second (2.i) class degree in a relevant subject.
By time of interview all potential students must have fulfilled language requirements for admission.
(http://www.graduate.study.cam.ac.uk/courses/directory/blpapdpth/requirements).


Applications from ineligible candidates will not be considered.